FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Qualgen Testosterone 200mg pellet Recall

Testosterone 200mg pellet, 1 count (NDC 69761-120-01), 6 count (NDC 69761-120-06), 12 c…

Qualgen, LLC · Edmond, OK

Risk level
Class II
Reported by FDA
Nov 14, 2018
Recall ID
D-0233-2019
Check your lot numberHow we source this data

Summary

Qualgen recalled Testosterone 200mg pellet starting Oct 17, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0233-2019 on Nov 14, 2018. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

Testosterone 200mg pellet, 1 count (NDC 69761-120-01), 6 count (NDC 69761-120-06), 12 count (NDC 69761-120-12), and 30 count (NDC 69761-120-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013

Lot numbers, UPCs & expiration codes

Lots: C230 BUD: 11/1/2018; C233 BUD: 11/3/2018; C234 BUD: 11/9/2018; C237 BUD: 11/13/2018; C240 BUD: 11/15/2018; C242 BUD: 11/20/2018; C244 BUD: 11/27/2018; C248 BUD: 12/4/2018; C250 BUD: 12/6/2018; C252 BUD: 12/12/2018; C256 BUD: 12/14/2018; C258 BUD: 12/18/2018; C264 BUD: 12/27/2018; D006 BUD: 1/8/2019; D009 BUD: 1/10/2019; D013 BUD: 1/15/2019; D015 BUD: 1/17/2019; D019 BUD: 1/22/2019; D024 BUD: 1/29/2019; D028 BUD: 2/1/2019; D034 BUD: 2/8/2019; D041 BUD: 2/20/2019; D059 BUD: 3/13/2019; D063 BUD: 3/15/2019; D070 BUD: 3/26/2019

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0233-2019
Classification
Class II
Status
Terminated
Recall initiated
Oct 17, 2018
FDA report date
Nov 14, 2018
Recall type
Voluntary: Firm initiated
Recalling firm
Qualgen, LLC

Original FDA data

Every field from FDA enforcement report D-0233-2019, exactly as published.

Show all FDA fields
City
Edmond
State
OK
Status
Terminated
Country
United States
Event ID
81346
Address
14844 Bristol Park Blvd
Code information
Lots: C230 BUD: 11/1/2018; C233 BUD: 11/3/2018; C234 BUD: 11/9/2018; C237 BUD: 11/13/2018; C240 BUD: 11/15/2018; C242 BUD: 11/20/2018; C244 BUD: 11/27/2018; C248 BUD: 12/4/2018; C250 BUD: 12/6/2018; C252 BUD: 12/12/2018; C256 BUD: 12/14/2018; C258 BUD: 12/18/2018; C264 BUD: 12/27/2018; D006 BUD: 1/8/2019; D009 BUD: 1/10/2019; D013 BUD: 1/15/2019; D015 BUD: 1/17/2019; D019 BUD: 1/22/2019; D024 BUD: 1/29/2019; D028 BUD: 2/1/2019; D034 BUD: 2/8/2019; D041 BUD: 2/20/2019; D059 BUD: 3/13/2019; D063 BUD: 3/15/2019; D070 BUD: 3/26/2019
Postal code
73013-1891
Report date
Nov 14, 2018
Product type
Drugs
Recall number
D-0233-2019
Classification
Class II
Recalling firm
Qualgen, LLC
Termination date
Jun 4, 2020
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone 200mg pellet, 1 count (NDC 69761-120-01), 6 count (NDC 69761-120-06), 12 count (NDC 69761-120-12), and 30 count (NDC 69761-120-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013
Distribution pattern
Nationwide.
Recall initiation date
Oct 17, 2018
Initial firm notification
Letter
Center classification date
Nov 7, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0233-2019, published Nov 14, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls